Neoadjuvant Selective RET Inhibitor for Medullary Thyroid Cancer: A Case Series.
Contrera KJ, Gule-Monroe MK, Hu MI, Cabanillas ME, Busaidy NL, Dadu R, Waguespack SG, Wang JR, Maniakas A, Lai SY, Diersing J, Kwon M, Grubbs EG, Subbiah V, Williams MD, Zafereo ME.
Contrera KJ, et al. Among authors: gule monroe mk.
Thyroid. 2023 Jan;33(1):129-132. doi: 10.1089/thy.2022.0506.
Thyroid. 2023.
PMID: 36503246
No abstract available.